Zhong Zhao
Chief Executive Officer at ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
Net worth: 120 M $ as of 2024-03-30
Zhong Zhao active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. | Chief Executive Officer | 2012-11-05 | - |
| Chairman | 2012-11-05 | - | |
| Founder | 2012-11-05 | - | |
| AVINGER, INC. | Director/Board Member | 2024-03-04 | - |
| Independent Dir/Board Member | 2024-03-04 | - |
Career history of Zhong Zhao
Former positions of Zhong Zhao
| Companies | Position | Start | End |
|---|---|---|---|
Cordis Corp.
 Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Corporate Officer/Principal | 2002-06-30 | 2011-07-31 |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Corporate Officer/Principal | 1996-06-30 | 2002-05-31 |
Training of Zhong Zhao
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Statistics
International
| United States | 5 |
| China | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| AVINGER, INC. | Health Technology |
| ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Cordis Corp.
Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Health Technology |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
- Stock Market
- Insiders
- Zhong Zhao
- Experience
